Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-05-01 00:00:00 ET · period of report 2023-04-29 · accession 0001062993-23-009749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-01 | 2023-04-29 | BIO | Last Andrew J. | EVP, COO | F - Tax | $450.79 | -346 | 3,767 | -8% | -$156.0K |
| D | 2023-05-01 | 2023-04-29 | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | +1,000 | 4,113 | +32% | $0 |
| D | 2023-05-01 | 2023-04-29 | BIO | Last Andrew J. | EVP, COO | M - OptEx | $0.00 | -1,000 | 1,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-04-29 | F | D | 346 | $450.79 | 3,766.62 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2023-04-29 | M | A | 1,000 | $0.00 | 4,112.62 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively. |
| 3 | Derivative | Restricted Stock Units | 2023-04-29 | M | D | 1,000 | $0.00 | 1,000 | D | $0.00 · — to — | 1,000 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |